12:13PM 12/08/09
'Fast Money' Recap: A Disturbing Selloff
The trading panel discussed the the sharp selloff at the end of today's trading session.
08:31PM 12/03/09
Verizon FiOS TV Celebrates Thanksgiving With A 'Feast Of Fury' From EPIX
Action Adventure Movie Marathon From EPIX Kicks Off Nov. 26 on FiOS TV VOD, Keeping Viewers Awake and Entertained After a Full Meal
09:45AM 11/23/09
Mass. Biotech Firm Explores Strategic Alternatives
Mass. biotech firm Epix Pharmaceuticals exploring strategic alternatives
10:00PM 05/11/09
Epix Says It May File For Bankruptcy Protection
Epix Pharmaceuticals may file for bankruptcy protection; offers cash and stock for debt
05:16PM 04/07/09
This Holding Is Taking Advantage of a Shift (Action Alerts PLUS $)
The move to 4G wireless technology will be a big driver for this stock.
09:59AM 01/06/09
Try the 'Anti-Arbitrage' Merger Play (RealMoney.com $)
When merger deals fall apart, the target's stock often sinks and then quickly rebounds.
11:29AM 11/26/08
Epix Phone: Eek! It Has a Mouse!
Gary Krakow discusses the best and worst of Samsung's new Epix smartphone. It's fast, runs on the latest Windows Mobile operating system and is the first smartphone to sport an optical mouse pointing device.
01:59PM 11/09/08
Epix Phone: Eek! it Has a Mouse!
Gary Krakow discusses the best and worst of Samsung's new Epix smartphone. It's fast, runs on the latest Windows Mobile operating system and is the first smartphone to sport an optical mouse pointing device.
03:31PM 11/06/08

AT&T's Epix Smartphone Packs Powerful Punch
The compact 3G world phone from Samsung offers Windows Mobile 6.1 and more.
01:22PM 11/06/08
BlackBerry Makes 'Bold' Statement
The long-awaited Bold 9000 has really fast download speeds and a beefy CPU.
10:58AM 10/30/08
Biotech Mailbag: Study Boosts ImmunoGen
Genentech is advancing T-DM1, which uses ImmunoGen technology, into a phase III study as a second-line treatment for Her-2 positive metastatic breast cancer.
11:37AM 10/17/08
Genentech Study Good News for ImmunoGen (RealMoney.com $)
Genentech is advancing T-DM1, which uses ImmunoGen technology, into a phase III study as a second-line treatment for Her-2 positive metastatic breast cancer.
07:06AM 10/17/08
Biotech Mailbag: Epix Pharmaceuticals
It may be best to wait for data from two clinical studies on Alzheimer's drug PRX-03140 before making any predictions about its prospects.
06:59AM 09/05/08



Connect with TheStreet